On May 4, 2020 our Board of Directors approved our
Post# of 75001
The purchase price for the assets consists of a combination of cash, common stock, and assumption of indebtedness, including:
· $1,750,000 in cash, to be paid as follows:
o $250,000 to be paid on or before August 15, 2020
o $500,000 to be paid on or before November 30, 2020
o $750,000 to be paid in 9 monthly installments from May 2020 through January of 2021; and
o $250,000 to be paid on or before March 1, 2021
· 27,000,000 shares of our common stock to be issued to Raw Pharma or its designees; and
· Assumption or re-financing of Raw Pharma’s bank debts secured by the equipment in the amount of $1,007,000. Beginning June 15, 2020, we are required to make monthly note payments on the equipment of $20,000 until the bank debt is refinanced or paid off; and
· Assumption of the premises lease for the plant, and assumption of certain equipment leases.
https://www.otcmarkets.com/filing/html?id=141...Fk04lbWj3h